Published September 2018 | Version v1
Journal article

Correlation between high expression levels of jumonji domain-containing 4 and short survival in cases of colon adenocarcinoma

  • 1. School of Pharmacy, National Defense Medical Center, Taipei (China)
  • 2. Department of Otorhinolaryngology-Head and Neck Surgery, Tri-Service General Hospital, Taipei (China)
  • 3. School of Medicine, Chung Shan Medical University, Taichung (China)
  • 4. Department of Pathology, Changhua Christian Hospital, Changhua (China)
  • 5. International Joint Center for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng, Henan (China)
  • 6. Department of Biological Sciences, National University of Singapore (Singapore)
  • 7. Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli (China)

Description

Highlights: • The play an important role of JMJD4 high expression in tumorgenesis of colon adenocarcinoma. • JMJD4 protein expression in colon adenocarcinoma was associated with histological grade and M-class. • The high expression of JMJD4 was significantly related with poor survival in patients with colon adenocarcinoma. • Cox proportional-hazards model analysis indicated JMJD4 could be a prognostic indicator for overall survival. In this study, we investigated the expression of jumonji domain-containing 4 (JMJD4) in colon adenocarcinoma (CA) look for evidences for future studies on clinical diagnostic and prognostic value. The immunohistochemical (IHC) reactivity of JMJD4 was assessed in human tissue microarrays using monoclonal antibodies. An initial investigation revealed that the expression of JMJD4 protein was significantly higher in tumor tissue of the colon and liver than in normal tissue. Upon further investigation, we observed significant positivity of JMJD4 between 59 paired samples from CA tissue and adjacent normal tissue. JMJD4 protein expression in CA differed significantly according to the histological grade and M-class (distant metastasis). We also determined that the mRNA or protein expression of JMJD4 was significantly associated with poor survival in patients with CA. Finally, univariate and multivariate analysis revealed that JMJD4 expression could be a prognostic indicator for patients with CA and may provide a new target for the development of novel therapies for the treatment of CA.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2018.07.061

Additional details

Identifiers

DOI
10.1016/j.bbrc.2018.07.061;
PII
S0006291X18315560;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
503
Journal Issue
3
Journal Page Range
p. 1442-1449
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53022037
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CARCINOMAS; LARGE INTESTINE; LIVER; MESSENGER-RNA; PROTEINS
Descriptors DEC
BODY; DIGESTIVE SYSTEM; DISEASES; GASTROINTESTINAL TRACT; GLANDS; INTESTINES; NEOPLASMS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RNA

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.